S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 47 of 47

Issue Date	Title / Author(s) / Citation	File
2006	MRI for pretreatment lymph node staging in uterine cervical cancer Choi, Hyuck Jae; Kim, Seung Hyup; Seo, San-Soo; Kang, Sokbom; Lee, Sun; Kim, Joo-Young; Kim, Young Hoon; Lee, Jong Seok; Chung, Hyun Hoon; Lee, Joo-Hyuk; Park, Sang-Yoon AJR 2006; 187:W538-W543	view file DOI
2006-06	Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis Koo, Kyung-Hoi; Lee, Jong Seok; Lee, Yun Jong; Kim, Ki-Jeong; Yoo, Jeong Joon; Kim, Hee Joong J Orthop Res24:1722-1728	link
2006-06	Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis Koo, Kyung-Hoi; Lee, Jong Seok; Lee, Yun Jong; Kim, Ki-Jeong; Yoo, Jeong Joon; Kim, Hee Joong J Orthop Res. 2006 Aug;24(8):1722-8.	link
2006-10	MRI for pretreatment lymph node staging in uterine cervical cancer Choi, Hyuck Jae; Kim, Seung Hyup; Seo, San-Soo; Kang, Sokbom; Lee, Sun; Kim, Joo-Young; Kim, Young Hoon; Lee, Jong Seok; Chung, Hyun Hoon; Lee, Joo-Hyuk AJR Am J Roentgenol 2006; 187:W538-543	DOI
2007-05	Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation Cho, Yo-Han; Lim, Hyun-Ae; Lee, Mark Hong; Kim, Inho; Lee, Jong Seok; Park, Seong yang; Kim, Byoung Kook; Yoon, Sung-Soo Clin Transplant. 2007 May-Jun;21(3):417-22.	link
2007-05	Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation Cho, Yo-Han; Lim, Hyun-Ae; Lee, Mark Hong; Kim, Inho; Lee, Jong Seok; Park, Seong yang; Kim, Byoung Kook; Yoon, Sung-Soo Clin Transplant. 2007 May-Jun;21(3):417-22.	link
2007-10	Palliative chemotherapy for pulmonary pleomorphic carcinoma Bae, Hyun-Mi; Min, Hye Sook; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong-Seok; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.58 No.1, pp.112-115	DOI
2007-11	Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer Park, Joon Oh; Kim, Sang-We; Ahn, Jin Seok; Suh, Cheolwon; Lee, Jung Shin; Jang, Joung Soon; Cho, Eun Kyung; Yang, Sung Hyun; Choi, Jin-Hyuk; Heo, Dae Seog; Park, Suk Young; Shin, Sang Won; Ahn, Myung Ju; Lee, Jong Seok; Yun, Young Ho; Lee, Jae-Won; Park, Keunchil J Clin Oncol 25:5233-5239	link
2007-11	Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer Park, Joon Oh; Kim, Sang-We; Ahn, Jin Seok; Suh, Cheolwon; Lee, Jung Shin; Jang, Joung Soon; Cho, Eun Kyung; Yang, Sung Hyun; Choi, Jin-Hyuk; Heo, Dae Seog; Park, Suk Young; Shin, Sang Won; Ahn, Myung Ju; Lee, Jong Seok; Yun, Young Ho; Lee, Jae-Won; Park, Keunchil J Clin Oncol. 2007 Nov 20;25(33):5233-9.	link
2008-02	Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity Oh, So Yeon; Kim, Jee Hyun; Lee, Keun-Wook; Bang, Soo-Mee; Hwang, Jin-Hyeok; Oh, Doyeun; Lee, Jong Seok Thromb Res. 2008;122(4):485-90	link
2008-03	Weight changes after adjuvant treatment in Korean women with early breast cancer Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok Breast Cancer Res Treat. 2009 ;114(1):147-53.	link
2009	Automated measurement of colonic polyps on CT colonography in anthropomorphic pig phantoms : Comparison between two commercial systems and effect of polyp morphology 이종석	link
2009-01	Efficacy and Toxicity of Pemetrexed as a Third-line Treatment for Non-small Cell Lung Cancer Sun, Jong-Mu; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Yu Jung; Lee, Jae-Ho; Lee, Jong Seok; Lee, Choon-Taek; Yoon, Ho Il JAPANESE JOURNAL OF CLINICAL ONCOLOGY; Vol.39 1; 27-32	DOI
2009-08	Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer Kim, Hee Jun; Kim, Yu Jung; Seo, Myung-Deok; Yi, Hyeon Gyu; Lee, Se-Hoon; Lee, Sang-Min; Kim, Dong-Wan; Yang, Seok-Chul; Lee, Choon-Taek; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog Lung Cancer, Vol.65 No.2, pp.242-246	DOI
2009-11	Acute Health Effects of Hebei Spirit Oil Spill Ha, Mina; Kwon, Hojang; Ha, Eun-Hee; Hong, Yun-Chul; Chung, Bong Chul; Kim, Eun-Jung; Lee, Seung-Min; Hur, Jongil; Jeong, Woo-Chul; Cheong, Hae-Kwan; Choi, Yeyong; Lee, Jeongae; Lee, Jong Seong EPIDEMIOLOGY; Vol.20(6); S250-S251	DOI
2009-11	Incidence and Biologic Features of 5q Deletion and 5q-Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008. Lee, Hye Ryun; Hong, Dae Sik; Zang, Dae Young; Lee, Hong Ghi; Kim, Hyeoung-Joon; Ahn, Jae-Sook; Cheong, June-Won; Bang, Soo-Mee; Yun, Yeo Min; Lee, Dong Soon; Lee, You Kyung; Min, Yoo-Hong; Park, Su Yon; Lee, Kyung-A; Lee, Jong-Seok; Kim, Inho; Yoon, Hwi-Joong BLOOD; Vol.114 22; 1087-1087
2010-01	Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60 Park, Sook Ryun; Cho, Hyo Jin; Moon, Kyung Jin; Chun, Kyung-Hee; Yoon, Sung-Soo; Park, Seonyang; Lee, Jong Seok; Kong, Sun-Young LEUKEMIA & LYMPHOMA; Vol.51 1; 132-145	DOI
2010-09	Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer Choi, In Sil; Lee, Keun-Wook; Kim, Ki Hwan; Kim, Yu Jung; Lee, Jong Seok; Kim, Jee Hyun MEDICAL ONCOLOGY; Vol.27 3; 992-997	DOI
2010-11	Allogeneic Stem Cell Transplantation (alloSCT) and Donor Lymphocyte Infusion (DLI) In Patients with Non-Hodgkin Lymphoma (NHL) Who Experienced Relapse or Progression After Autologous Stem Cell Transplantation (autoSCT): Retrospective Analysis From the Korean Society of Blood and Marrow Transplantation. Kim, Ji-Won; Kim, Byung-Su; Bang, Soo-Mee; Kim, Inho; Kim, Won Seog; Lee, Je-Jung; Kim, Jin Seok; Yhim, Ho-Young; Yoon, Sung-Soo; Kim, Byoung Kook; Park, Seonyang; Lee, Jong Seok; Kwak, Jae-Yong; Sohn, Sang Kyun; Lee, Je-Hwan; Yang, Deok-Hwan; Kim, Dong Hwan BLOOD; Vol.116 21; 1454-1454
2010-11	Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies Kim, Ji-Won; Kim, Kyung Im; Lee, Hyun Jung; Kim, Byung-Su; Kim, Inho; Yoon, Sung-Soo; Park, Seonyang; Kim, Byoung Kook; Lee, Jong Seok; Oh, Jung Mi; Bang, Soo-Mee BLOOD; Vol.116 21; 399-399
2011-01	A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinonna harboring EGFR mutations Kim, Dong-Wan; Lee, Se-Hoon; Lee, Jong Seok; Lee, Myung Ah; Kang, Jin Hyoung; Kim, Si Young; Shin, Sang Won; Kim, Hoon-Kyo; Heo, Dae Seog Lung Cancer, Vol.71 No.1, pp.65-69	DOI
2011-08	Predictive factors for long-term response to pemetrexed treatment in advanced non-squamous, non-small cell lung cancer patients 권지현	link
2014-11	A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Oncologist, Vol.19 No.11, pp.1129-1130	DOI
2015-03	Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL) Kim, Miso; Kim, Tae Min; Kim, Ki Hwan; Keam, Bhumsuk; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Annals of Hematology, Vol.94 No.3, pp.437-444	DOI
2015-06	Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer Sim, Sung Hoon; Kim, Yu Jung; Kim, Se Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Journal of Cancer Research and Clinical Oncology, Vol.141 No.6, pp.1073-1081	DOI
2015-10	Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations Park, Sehhoon; Keam, Bhumsuk; Kim, Se Hyun; Kim, Ki Hwan; Kim, Yu Jung; Kim, Jin-Soo; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.47 No.4, pp.630-637	view file DOI
2017-04	Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer Kim, Miso; Keam, Bhumsuk; Kim, Tae-Min; Kim, Hoon-Gu; Kim, Jin-Soo; Lee, Sung Sook; Shin, Seong Hoon; Kim, Min Kyoung; Park, Keon Uk; Kim, Dong-Wan; Yun, Hwan Jung; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.49 No.2, pp.416-422	view file DOI
2017-09	Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas Lee, June-Koo; Lee, Junehawk; Kim, Sehui; Kim, Soyeon; Youk, Jeonghwan; Park, Seongyeol; An, Yohan; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog; Kim, Young Tae; Kim, Jin-Soo; Kim, Se Hyun; Lee, Jong Seok; Lee, Se-Hoon; Park, Keunchil; Ku, Ja-Lok; Jeon, Yoon Kyung; Chung, Doo Hyun; Park, Peter J.; Kim, Joon; Kim, Tae Min; Ju, Young Seok Journal of Clinical Oncology, Vol.35 No.26, pp.3065-3074	DOI
2017-11	Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study Ahn, Myung-Ju; Kim, Dong-Wan; Cho, Byoung Chul; Kim, Sang-We; Lee, Jong Seok; Ahn, Jin-Seok; Kim, Tae Min; Lin, Chia-Chi; Kim, Hye Ryun; John, Thomas; Kao, Steven; Goldman, Jonathan W.; Su, Wu-Chou; Natale, Ronald; Rabbie, Sarit; Harrop, Bryony; Overend, Philip; Yang, Zhenfan; Yang, James Chih-Hsin The Lancet Respiratory Medicine, Vol.5 No.11, pp.891-902	DOI
2018-03	Efficacy of pemetrexed-based chemotherapy in comparison to non-pemetrexed-based chemotherapy in advanced, ALK plus non-small cell lung cancer Jo, Jaemin; Kim, Se Hyun; Kim, Yu Jung; Lee, Juhyun; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Chung, Jin-Haeng; Jeon, Yoon Kyung; Lee, Jong Seok Yonsei Medical Journal, Vol.59 No.2, pp.202-210	view file DOI
2018-03	Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody Suh, Koung Jin; Kim, Se Hyun; Kim, Yu Jung; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Cancer Immunology, Immunotherapy, Vol.67 No.3, pp.459-470	DOI
2018-08	Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy Lee, Jong Seok; Lee, Ki Hyeong; Cho, Eun Kyung; Kim, Dong-Wan; Kim, Sang-We; Kim, Joo-Hang; Cho, Byoung Chul; Kang, Jin Hyoung; Han, Ji-Youn; Min, Young Joo; Park, Keunchil Lung Cancer, Vol.122, pp.234-242	DOI
2018-08	Low-dose nivolumab can be effective in non-small cell lung cancer: Alternative option for financial toxicity Yoo, Shin Hye; Keam, Bhumsuk; Kim, Miso; Kim, Se Hyun; Kim, Yu Jung; Kim, Tae Min; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Esmo Open, Vol.3 No.5, p. e000332	DOI
2018-11	Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin -H.; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Ffrank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay New England Journal of Medicine, Vol.379 No.21, pp.2027-2039	DOI
2019-01	Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors Kim, Ryul; Keam, Bhumsuk; Kim, Sehui; Kim, Miso; Kim, Se Hyun; Kim, Jin Wook; Kim, Yu Jung; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong Seok; Heo, Dae Seog BMC Cancer, Vol.19 No.1, p. 19	view file DOI
2019-05	Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M-Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report Yang, James Chih-Hsin; Shepherd, Frances A.; Kim, Dong-Wan; Lee, Gyeong-Won; Lee, Jong Seok; Chang, Gee-Chen; Lee, Sung Sook; Wei, Yu-Feng; Lee, Yun Gyoo; Laus, Gianluca; Collins, Barbara; Pisetzky, Francesca; Horn, Leora Journal of Thoracic Oncology, Vol.14 No.5, pp.933-939	DOI
2019-09	Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial Kim, Dong-Wan; Lee, Dae Ho; Han, Ji-Youn; Lee, Jongseok; Cho, Byoung Chul; Kang, Jin Hyoung; Lee, Ki Hyeong; Cho, Eun Kyung; Kim, Jin-Soo; Min, Young Joo; Cho, Jae Yong; An, Ho Jung; Kim, Hoon-Gu; Lee, Kyung Hee; Kim, Bong-Seog; Jang, In-Jin; Yoon, Seonghae; Han, OakPil; Noh, Young Su; Hong, Ka Young; Park, Keunchil Lung Cancer, Vol.135, pp.66-72	DOI
2019-10	A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer Kim, Yu-Jung; Keam, Bhumsuk; Ock, Chan-Young; Song, Sanghoon; Kim, Miso; Kim, Se Hyun; Kim, Ki Hwan; Kim, Jin-Soo; Kim, Tae Min; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Lung Cancer, Vol.136, pp.122-128	DOI
2019-11	The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer Heo, Ja Yoon; Park, Changhee; Keam, Bhumsuk; Ock, Chan-Young; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Kim, Se Hyun; Kim, Yu Jung; Lee, Jong Seok; Heo, Dae Seog Thoracic Cancer, Vol.10 No.11, pp.2117-2123	view file DOI
2019-12	Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study Ahn, Myung-Ju; Han, Ji-Youn; Lee, Ki Hyeong; Kim, Sang-We; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok; Min, Young Joo; Kim, Jin-Soo; Lee, Sung Sook; Kim, Hye Ryun; Hong, Min Hee; Ahn, Jin Seok; Sun, Jong-Mu; Kim, Heung Tae; Lee, Dae Ho; Kim, Sohee; Cho, Byoung Chul The Lancet Oncology, Vol.20 No.12, pp.1681-1690	DOI
2020	Resistance Mechanism to Pemetrexed According to Genetic Characteristics of Lung Cancer Cell Lines 권지현	view file link
2020-01	Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies Ahn, Myung-Ju; Han, Ji-Youn; Kim, Dong-Wan; Cho, Byoung Chul; Kang, Jin-Hyoung; Kim, Sang-We; Yang, James Chih-Hsin; Mitsudomi, Tetsuya; Lee, Jong Seok Cancer Research and Treatment, Vol.52 No.1, pp.284-291	view file DOI
2020-02	Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: The BLOOM study Yang, James C. H.; Kim, Sang-We; Kim, Dong-Wan; Lee, Jong-Seok; Cho, Byoung Chul; Ahn, Jin-Seok; Lee, Dae H.; Kim, Tae Min; Goldman, Jonathan W.; Natale, Ronald B.; Brown, Andrew P.; Collins, Barbara; Chmielecki, Juliann; Vishwanathan, Karthick; Mendoza-Naranjo, Ariadna; Ahn, Myung-Ju Journal of Clinical Oncology, Vol.38 No.6, pp.538-547	DOI
2020-03	Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Cho, Byoung Chul; Kim, Dong-Wan; Park, Keunchil; Lee, Jong-Seok; Yoo, Seung Soo; Kang, Jin Hyoung; Lee, Sung Yong; Kim, Cheol Hyeon; Jang, Seung Hun; Kim, Young-Chul; Yoon, Hyoung-Kyu; Han, Ji-Youn; Kim, Sang-We Current Medical Research and Opinion, Vol.36 No.3, pp.477-482	DOI
2020-12	Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07 Kim, Miso; Keam, Bhumsuk; Ock, Chan-Young; Kim, Se Hyun; Kim, Yu Jung; Lim, Sun Min; Kim, Jin-Soo; Kim, Tae Min; Hong, Sook-Hee; Ahn, Mi Sun; Shin, Seong Hoon; Kang, Eun Joo; Kim, Dong-Wan; Im, Sun-Wha; Kim, Jong-Il; Lee, Jong Seok; Kim, Joo-Hang; Heo, Dae Seog Thoracic Cancer, Vol.11 No.12, pp.3482-3489	DOI
2021-01	Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients Heo, Ja Yoon; Yoo, Shin Hye; Suh, Koung Jin; Kim, Se Hyun; Kim, Yu Jung; Ock, Chan-Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Scientific Reports, Vol.11 No.1, p. 2514	DOI
2021-02	Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma Kang, Minsu; Park, Changhee; Kim, Se Hyun; Yoon, Sock Won; Suh, Koung Jin; Kim, Yu Jung; Ock, Chan-Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Translational Lung Cancer Research, Vol.10 No.2, pp.699-711	DOI